Is WeightLoss | SLIM DNA-Test useful for Blutzucker?

The 'WeightLoss | SLIM DNA-Test' is a commercial genetic test marketed to provide insights into weight and metabolic tendencies. However, it is not useful for assessing blood sugar levels. The SNPs included (e.g., in FTO, TCF7L2, PPARG) have very small effect sizes on fasting glucose or diabetes risk—typically explaining less than 5% of variance. Such consumer tests lack clinical validation for diagnosing prediabetes or diabetes. Evidence is mostly from GWAS and mechanistic associations, not from interventional trials. Moreover, they often miss key variants relevant to blood sugar regulation (e.g., in GCK, HNF1A). For reliable blood sugar evaluation, standard laboratory tests (fasting glucose, HbA1c, OGTT) are required. The test may serve as a conversation starter with a healthcare provider but should not guide medical decisions. Be cautious of marketing hype: the actual clinical utility for blood sugar management is minimal.